SLNSW-Ibrutinib (ImbruvicaTM) potently inhibits ErbB re...-TN_cdi_proquest_journals_1622204623

Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

Full title: Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

Author/creator: Grabinski, Nicole, Ewald, Florian.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1622204623

Language: English

Formats: Articles

Publishers: New York: Springer US

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1622204623

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

    Record identifier

    TN_cdi_proquest_journals_1622204623

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1622204623

    Share

    Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1622204623

    Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

    Full title

    Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells

    Author / Creator

    Grabinski, Nicole ; Ewald, Florian

    Publisher

    New York: Springer US

    Journal title

    Investigational new drugs, 2014, Vol.32 (6), p.1096-1104

    Record Identifier

    TN_cdi_proquest_journals_1622204623

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Agammaglobulinaemia Tyrosine Kinase Analysis Animals Antibodies Antineoplastic agents Antineoplastic Agents - pharmacology Binding sites Biological and medical sciences Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Cancer therapies Care and treatment Cell Line, Tumor Cell Survival - drug effects Complications and side effects Drug therapy ErbB Receptors - antagonists & inhibitors ErbB Receptors - metabolism Female Gynecology. Andrology. Obstetrics Health aspects Heterocyclic Compounds, 3-Ring - pharmacology Humans Imidazoles - pharmacology Inhibitor drugs Kinases Lymphoma Mammary gland diseases Medical sciences Medicine Medicine & Public Health Mice Mitogen-Activated Protein Kinases - metabolism Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Oncology Pharmaceutical sciences Pharmacology. Drug treatments Pharmacology/Toxicology Phosphoinositide-3 Kinase Inhibitors Phosphorylation Phosphorylation - drug effects Preclinical Studies Protein Kinase Inhibitors - pharmacology Protein-Tyrosine Kinases - antagonists & inhibitors Proteins Proto-Oncogene Proteins c-akt - metabolism Pyrazoles - pharmacology Pyrimidines - pharmacology Quinolines - pharmacology Signal transduction Software Studies TOR Serine-Threonine Kinases - antagonists & inhibitors Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1622204623

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1622204623

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    About resource >

    View in old catalogue

    Connecting people and collections